Medacta Group SA (LON:0A05)
London
· Delayed Price · Currency is GBP · Price in CHF 131.60
+2.20 (1.70%)
At close: Apr 25, 2025
Medacta Group Revenue
In the year 2024, Medacta Group had annual revenue of 590.58M EUR with 15.62% growth. Medacta Group had revenue of 301.93M in the half year ending December 31, 2024, with 33.69% growth.
Revenue
590.58M EUR
Revenue Growth
+15.62%
P/S Ratio
4.89
Revenue / Employee
309.69K EUR
Employees
1,907
Market Cap
2.39B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |